Correction of Anemia in Chronic Kidney Disease With Angelica sinensis Polysaccharide via Restoring EPO Production and Improving Iron Availability

• Hauptverfasser: Kaiping Wang (Verfasst von), Jun Wu (Verfasst von), Jingya Xu (Verfasst von), Saisai Gu (Verfasst von), Qiang Li (Verfasst von), Peng Cao (Verfasst von), Mingming Li (Verfasst von), Yu Zhang (Verfasst von), Fang Zeng (Verfasst von)
• Format: Buch
• Veröffentlicht: Frontiers Media S.A., 2018-07-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Given the limited efficacy and potential disadvantages of erythropoiesis-stimulating agents (ESAs) in treating anemia of chronic kidney disease (CKD), the development of better alternative therapies has become a priority. The primary purpose of this study is to investigate the effects of Angelica si...